BioSight For Profit
Innovative Cancer Targeted Pro-Drugs.
Investment Stage:
N/A
Number Of Exists:
N/A
Employee Number:
Carmiel, HaZafon, Israel
Estimated Revenue:
$1M to $10M
Headquarters:
Carmiel, HaZafon, Israel
Funding Status:
M&A
Founded Date:
1905-07-11
Industry:
PharmTech
Technology:
Drug development
Investor Type:
Company